ArticleJournal of immunotherapy and precision oncology2022

Selinexor in Combination with Carboplatin and Pemetrexed in Patients with Advanced or Metastatic Solid Tumors: Results of an Open-Label, Single-Center, Multi-Arm Phase 1b Study.

Kyaw Z Thein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.